Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 174392, 7 pages
http://dx.doi.org/10.1155/2013/174392
Research Article

Dual Silencing of Hsp27 and c-FLIP Enhances Doxazosin-Induced Apoptosis in PC-3 Prostate Cancer Cells

1Eulji Medi-Bio Research Institute, Seoul 139-871, Republic of Korea
2Department of Urology, College of Medicine, Eulji University, Hangeulbiseok-gil, Hagye-dong, Nowon-ku, Seoul 139-871, Republic of Korea
3Department of Biotechnology, Seoul Women’s University, Seoul 139-871, Republic of Korea

Received 22 April 2013; Accepted 22 May 2013

Academic Editors: A. Tefekli, V. Tugcu, and M. Tunc

Copyright © 2013 Sang Soo Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. F. Tannock, R. De Wit, W. R. Berry et al., “Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer,” New England Journal of Medicine, vol. 351, no. 15, pp. 1502–1512, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. D. P. Petrylak, C. M. Tangen, M. H. A. Hussain et al., “Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer,” New England Journal of Medicine, vol. 351, no. 15, pp. 1513–1520, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Cheetham and D. P. Petrylak, “Tubulin-targeted agents including docetaxel and cabazitaxel,” Cancer Journal, vol. 19, no. 1, pp. 59–65, 2013. View at Google Scholar
  4. M. N. Stein, S. Goodin, and R. S. DiPaola, “Abiraterone in prostate cancer: a new angle to an old problem,” Clinical Cancer Research, vol. 18, no. 7, pp. 1848–1854, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Bai, J. Sui, A. Demirjian, C. M. Vollmer Jr., W. Marasco, and M. P. Callery, “Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro,” Cancer Research, vol. 65, no. 6, pp. 2344–2352, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. S. D. Catz and J. L. Johnson, “BCL-2 in prostate cancer: a minireview,” Apoptosis, vol. 8, no. 1, pp. 29–37, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. H. Youm, H. Yang, Y.-D. Yoon, D.-Y. Kim, C. Lee, and T. K. Yoo, “Doxazosin-induced clusterin expression and apoptosis in prostate cancer cells,” Urologic Oncology, vol. 25, no. 6, pp. 483–488, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Rocchi, A. So, S. Kojima et al., “Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer,” Cancer Research, vol. 64, no. 18, pp. 6595–6602, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Glaessgen, S. Jonmarker, A. Lindberg et al., “Heat shock proteins 27, 60 and 70 as prognostic markers of prostate cancer,” Acta Pathologica, Microbiologica, et Immunologica Scandinavica, vol. 116, no. 10, pp. 888–895, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. A. R. Safa, T. W. Day, and C.-H. Wu, “Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy,” Current Cancer Drug Targets, vol. 8, no. 1, pp. 37–46, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Pootrakul, R. H. Datar, S.-R. Shi et al., “Expression of stress response protein Grp78 is associated with the development of castration-resistant prostate cancer,” Clinical Cancer Research, vol. 12, no. 20, pp. 5987–5993, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Zoubeidi, K. Chi, and M. Gleave, “Targeting the cytoprotective chaperone, clusterin, for treatment of advanced cancer,” Clinical Cancer Research, vol. 16, no. 4, pp. 1088–1093, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Lanneau, A. de Thonel, S. Maurel, C. Didelot, and C. Garrido, “Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27,” Prion, vol. 1, no. 1, pp. 53–60, 2007. View at Google Scholar · View at Scopus
  14. P. A. Cornford, A. R. Dodson, K. F. Parsons et al., “Heat shock protein expression independently predicts clinical outcome in prostate cancer,” Cancer Research, vol. 60, no. 24, pp. 7099–7105, 2000. View at Google Scholar · View at Scopus
  15. S. L. Lee, E. K. Kim, S. S. Kim, S. H. Uh, K. C. Cha, and T. K. Yoo, “Expression of heat shock protein 27 according to Gleason score and pathologic stage of prostate cancer,” Korean Journal of Urology, vol. 50, no. 6, pp. 547–552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. T. W. Day, S. Huang, and A. R. Safa, “c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells,” Biochemical Pharmacology, vol. 76, no. 12, pp. 1694–1704, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Zhang, T.-G. Jin, H. Yang, W. C. Dewolf, R. Khosravi-Far, and A. F. Olumi, “Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer,” Cancer Research, vol. 64, no. 19, pp. 7086–7091, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Korkolopoulou, A. A. Saetta, G. Levidou et al., “c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications,” Histopathology, vol. 51, no. 2, pp. 150–156, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Korkolopoulou, A. Goudopoulou, G. Voutsinas et al., “c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations,” Urology, vol. 63, no. 6, pp. 1198–1204, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. T. W. Day, A. L. Sinn, S. Huang, K. E. Pollok, G. E. Sandusky, and A. R. Safa, “C-FLIP gene silencing eliminates tumor cells in breast cancer xenografts without affecting stromal cells,” Anticancer Research, vol. 29, no. 10, pp. 3883–3886, 2009. View at Google Scholar · View at Scopus
  21. S. Kaulfuß, P. Burfeind, J. Gaedcke, and J.-G. Scharf, “Dual silencing of insulin-like growth factor-I receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis,” Molecular Cancer Therapeutics, vol. 8, no. 4, pp. 821–833, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. C. M. Benning and N. Kyprianou, “Quinazoline-derived α1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an α1-adrenoceptor-independent action,” Cancer Research, vol. 62, no. 2, pp. 597–602, 2002. View at Google Scholar · View at Scopus
  23. J. B. Garrison and N. Kyprianou, “Doxazosin induces apoptosis of benign and malignant prostate cells via a death receptor-mediated pathway,” Cancer Research, vol. 66, no. 1, pp. 464–472, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Kyprianou, T. B. Vaughan, and M. C. Michel, “Apoptosis induction by doxazosin and other quinazoline α1-adrenoceptor antagonists: a new mechanism for cancer treatment?” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 380, no. 6, pp. 473–477, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Kyprianou, “Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance,” Journal of Urology, vol. 169, no. 4, pp. 1520–1525, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. V. N. Kim, “RNA interference in functional genomics and medicine,” Journal of Korean Medical Science, vol. 18, no. 3, pp. 309–318, 2003. View at Google Scholar · View at Scopus
  27. P. Rocchi, E. Beraldi, S. Ettinger et al., “Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis,” Cancer Research, vol. 65, no. 23, pp. 11083–11093, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. D. B. Longley, T. R. Wilson, M. McEwan et al., “c-FLIP inhibits chemotherapy-induced colorectal cancer cell death,” Oncogene, vol. 25, no. 6, pp. 838–848, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. S. S. Kim, H. J. Cho, J. Y. Kang, H. K. Kang, and T. K. Yoo, “Inhibition of androgen receptor expression with small interfering RNA enhances cancer cell apoptosis by suppressing survival factors in androgen insensitive, late stage LNCaP cells,” The Scientific World Journal, vol. 2013, Article ID 519397, 8 pages, 2013. View at Publisher · View at Google Scholar